Utilità e limiti della medicina nucleare nel follow-up dei carcinomi differenziati della tiroide

Translated title of the contribution: Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma

Research output: Contribution to journalArticlepeer-review

Abstract

Radionuclide therapy using iodine-131 is widely employed in the work-up of differentiated thyroid carcinoma. After a brief introduction on physical and dosimetry characteristics of radioactive iodine, this paper suggests state of the arts protocol for the ablation of thyroid remnants and for the treatment of metastatic disease. Diagnostic applications of Nuclear Medicine in these tumors are critically evaluated as well, from the use of iodine-131 whole-body scan to 18F-FDG PET and other new diagnostic tools. Finally, a brief description of new radionuclide treatments is reported.

Translated title of the contributionUtility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma
Original languageItalian
Pages (from-to)215-222
Number of pages8
JournalAnnali Italiani di Chirurgia
Volume77
Issue number3
Publication statusPublished - May 2006

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma'. Together they form a unique fingerprint.

Cite this